Arcadia Biosciences, Inc. — Director's Dealing 2017

Jun 9, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2017-06-07

Reporting Person: Gosbee George Frederick John (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-07	Stock Option (right to buy)	$0.73	A	80466	Acquired	2027-06-07	Common Stock (80466)	Direct

Footnotes

F1: The Option will become 100% vested and excercisable on the earlier to occur of (i) June 7, 2018 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Particpant's continued service.